Submission for OMB Review; 30-Day Comment Request: Population Sciences Biospecimen Catalog (PSBC), 55141-55142 [2015-23027]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 177 / Monday, September 14, 2015 / Notices
Dated: September 9, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–23042 Filed 9–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Technologies/
Innovations for Improving Population Health
and Eliminating Health Disparities (R41/R42,
R43/R44).
Date: October 20, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Xinli Nan, MD, Ph.D.,
Scientific Review Officer, National Institute
on Minority Health and Health Disparities,
National Institutes of Health, Scientific
Review Branch, OERA, 6707 Democracy
Blvd., Suite 800, Bethesda, MD 20892, (301)
594–7784, Xinli.nan@nih.gov.
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel—Cancer
Therapeutics.
Date: September 22, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Careen K Tang-Toth,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 435–
3504, tothct@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.39–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 8, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–22985 Filed 9–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: September 9, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Submission for OMB Review; 30-Day
Comment Request: Population
Sciences Biospecimen Catalog (PSBC)
[FR Doc. 2015–23043 Filed 9–11–15; 8:45 am]
SUMMARY:
BILLING CODE 4140–01–P
tkelley on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
18:15 Sep 11, 2015
Jkt 235001
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute, the National Institutes
of Health, has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on (June 30, 2015 P.37280) and
allowed 60-days for public comment.
No public comments were received. The
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
55141
purpose of this notice is to allow an
additional 30 days for public comment.
The National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Danielle Carrick, Program
Director, Division of Cancer Control and
Population Sciences (DCCPS), National
Cancer Institute, 9609 Medical Center
Dr., Room 4E224, Rockville, MD 20850
or call non-toll-free number (240) 276–
6749 or Email your request, including
your address to: Danielle.Carrick@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
Proposed Collection: Population
Sciences Biospecimen Catalog (PSBC)
(NCI), 0925—NEW, National Cancer
Institute(NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: This is a request for approval
of a new collection. The National
Cancer Institute (NCI) Division of
Cancer Control and Population Sciences
(DCCPS) has previously demonstrated
that approximately 60% of population
based studies funded by the division
use existing biospecimens from other
collections, and that those studies are
more cost and time efficient than
studies collecting new specimens. Yet,
it is difficult for researchers to identify
potentially appropriate sources for
biospecimens and accompanying
epidemiologic and exposure data.
Development of a searchable inventory
of population-based biospecimen
resources was a major recommendation
resulting from an NCI think tank held in
August 2013 (‘‘Utilizing Existing
Clinical and Population Biospecimen
Resources for Discovery or Validation of
E:\FR\FM\14SEN1.SGM
14SEN1
55142
Federal Register / Vol. 80, No. 177 / Monday, September 14, 2015 / Notices
Markers for Early Cancer Detection’’)
and would also be directly addressing
four of the key recommendations that
emerged in an NCI sponsored workshop
titled ‘‘Trends in 21st Century
Epidemiology: From Scientific
Discoveries to Population Health’’
(CEBP, 2013, issue 22, page 508). In
response to this, NCI DCCPS is
developing a biospecimen inventory
and online searchable catalog (or
‘‘Population Sciences Biospecimen
Catalog (PSBC)’’). The PSBC allows
scientists in the research community
and the NCI to locate specimens
appropriate for their population based
research projects. It is not NCI’s intent
to collect biospecimens; rather the
collections are descriptions of the
available data that can act as a resource
and be shared with researchers and
scientists who are interested. This
submission is via data upload to the
secure Web site in order to collect
information to manage and improve a
program and its resources for the use by
all scientists.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
80.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
time per
response
( in hours)
Total annual
burden hour
Form name
Type of respondent
Population Sciences Biospecimen Catalog Initial
Request.
Private Sector ...............
30
1
1
30
State Government ........
Private Sector ...............
30
30
1
1
1
20/60
30
10
State Government ........
30
1
20/60
10
Population Sciences Biospecimen Catalog Annual Update.
Dated: September 1, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National
Cancer Institute, NIH.
[FR Doc. 2015–23027 Filed 9–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Characterization of
Risk of HIV and HIV Outcomes in the
Brazilian Sickle Cell Disease (SCD)
Population and Comparison of SCD
Outcomes Between HIV Sero-Positive
and Negative SCD (NHLBI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Heart, Lung, and Blood Institute
(NHLBI), the National Institutes of
Health (NIH) has submitted to the Office
of Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on June 8, 2015 (80 FR 32388)
and allowed 60-days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:15 Sep 11, 2015
Jkt 235001
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: Desk Officer for NIH.
DATES: Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Simone Glynn, MD, Project
Officer/ICD Contact, Two Rockledge
Center, Suite 9142, 6701 Rockledge
Drive, Bethesda, MD 20892, or call 301–
435–0065, or Email your request,
including your address to: glynnsa@
nhlbi.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Characterization
of risk of HIV and HIV outcomes in the
Brazilian Sickle Cell Disease (SCD)
population and comparison of SCD
outcomes between HIV sero-positive
and negative SCD patients 0925–NEW,
National Heart, Lung, and Blood
Institute (NHLBI), the National
Institutes of Health (NIH).
Need and Use of Information
Collection: The National Heart, Lung,
and Blood Institute (NHLBI) Recipient
Epidemiology and Donor Evaluation
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Study-III (REDS–III) program conducts
research focused on the safety of the
blood supply, the patients who are in
need of transfusions, and the
epidemiology of transfusiontransmissible infections such as human
immunodeficiency virus (HIV). Sickle
cell disease (SCD) is a blood disorder
that affects thousands of people in the
United States and Brazil. Many patients
with SCD need to be chronically
transfused with red blood cells and the
REDS–III research program has
established in Brazil a cohort of patients
with SCD to study transfusion outcomes
and infectious diseases such as HIV in
the SCD population.
Sickle cell disease predominantly
affects persons with sub-Saharan Africa
and other malaria-endemic regions
ancestry because people who carry one
sickle cell disease gene (you need 2 to
have sickle cell disease) have a survival
advantage for malaria. Sub-Saharan
Africa, where most people with SCD in
the world live, remains one of the
regions most severely affected by HIV,
with nearly 1 in every 20 adults living
with the virus. In the United States, HIV
also disproportionately affects persons
with African ancestry. Despite the
diseases’ occurrence in similar
populations and the fact that both HIV
and SCD are independent predictors of
outcomes such as stroke, there is a lack
of data to evaluate if patients with SCD
and HIV have different illnesses than
patients who have SCD- or HIV-only.
The proposed study will seek to
understand the risk of HIV in the SCD
population, describe HIV outcomes in
patients with SCD and compare SCD
complications between HIV-positive
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 80, Number 177 (Monday, September 14, 2015)]
[Notices]
[Pages 55141-55142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23027]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request: Population
Sciences Biospecimen Catalog (PSBC)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Cancer Institute, the National
Institutes of Health, has submitted to the Office of Management and
Budget (OMB) a request for review and approval of the information
collection listed below. This proposed information collection was
previously published in the Federal Register on (June 30, 2015 P.37280)
and allowed 60-days for public comment. No public comments were
received. The purpose of this notice is to allow an additional 30 days
for public comment. The National Cancer Institute (NCI), National
Institutes of Health, may not conduct or sponsor, and the respondent is
not required to respond to, an information collection that has been
extended, revised, or implemented on or after October 1, 1995, unless
it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, or request more information on the
proposed project, contact: Danielle Carrick, Program Director, Division
of Cancer Control and Population Sciences (DCCPS), National Cancer
Institute, 9609 Medical Center Dr., Room 4E224, Rockville, MD 20850 or
call non-toll-free number (240) 276-6749 or Email your request,
including your address to: Danielle.Carrick@nih.gov. Formal requests
for additional plans and instruments must be requested in writing.
Proposed Collection: Population Sciences Biospecimen Catalog (PSBC)
(NCI), 0925--NEW, National Cancer Institute(NCI), National Institutes
of Health (NIH).
Need and Use of Information Collection: This is a request for
approval of a new collection. The National Cancer Institute (NCI)
Division of Cancer Control and Population Sciences (DCCPS) has
previously demonstrated that approximately 60% of population based
studies funded by the division use existing biospecimens from other
collections, and that those studies are more cost and time efficient
than studies collecting new specimens. Yet, it is difficult for
researchers to identify potentially appropriate sources for
biospecimens and accompanying epidemiologic and exposure data.
Development of a searchable inventory of population-based biospecimen
resources was a major recommendation resulting from an NCI think tank
held in August 2013 (``Utilizing Existing Clinical and Population
Biospecimen Resources for Discovery or Validation of
[[Page 55142]]
Markers for Early Cancer Detection'') and would also be directly
addressing four of the key recommendations that emerged in an NCI
sponsored workshop titled ``Trends in 21st Century Epidemiology: From
Scientific Discoveries to Population Health'' (CEBP, 2013, issue 22,
page 508). In response to this, NCI DCCPS is developing a biospecimen
inventory and online searchable catalog (or ``Population Sciences
Biospecimen Catalog (PSBC)''). The PSBC allows scientists in the
research community and the NCI to locate specimens appropriate for
their population based research projects. It is not NCI's intent to
collect biospecimens; rather the collections are descriptions of the
available data that can act as a resource and be shared with
researchers and scientists who are interested. This submission is via
data upload to the secure Web site in order to collect information to
manage and improve a program and its resources for the use by all
scientists.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 80.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Type of Number of responses per per response ( Total annual
respondent respondents respondent in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Population Sciences Private Sector.. 30 1 1 30
Biospecimen Catalog Initial
Request.
State Government 30 1 1 30
Population Sciences Private Sector.. 30 1 20/60 10
Biospecimen Catalog Annual
Update.
State Government 30 1 20/60 10
----------------------------------------------------------------------------------------------------------------
Dated: September 1, 2015.
Karla Bailey,
NCI Project Clearance Liaison, National Cancer Institute, NIH.
[FR Doc. 2015-23027 Filed 9-11-15; 8:45 am]
BILLING CODE 4140-01-P
